Understanding how CD8 T cells work in lung cancer
The ontogeny and function of CD8 T cells in lung cancer
This study is looking at how certain immune cells called CD8 T cells work in lung cancer, especially in patients with non-small cell lung cancer, to find better ways to boost treatments that help the body fight the disease.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11018496 on NIH RePORTER |
What this research studies
This research investigates the role of CD8 T cells in lung cancer, particularly focusing on non-small cell lung cancer (NSCLC). The study aims to understand how these immune cells develop and function in the lung environment during cancer progression. By examining the T cell response over time, the researchers hope to identify ways to enhance the effectiveness of immunotherapy for lung cancer patients. This involves studying specific T cell populations that may be more effective in fighting tumors and determining how to generate these cells for therapeutic use.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with non-small cell lung cancer who are seeking innovative treatment options.
Not a fit: Patients with other types of lung cancer or those who are not eligible for immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapy treatments for lung cancer, potentially increasing the number of patients who respond positively to these therapies.
How similar studies have performed: Previous research has shown promise in enhancing immune responses in cancer treatment, but this specific approach to understanding CD8 T cells in lung cancer is relatively novel.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Schenkel, Jason M. — University of Tx Md Anderson Can Ctr
- Study coordinator: Schenkel, Jason M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.